Literature DB >> 24168232

Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols.

Tae Heon Kim1, Hwang Gyun Jeon, Seol Ho Choo, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, Hyun Moo Lee.   

Abstract

OBJECTIVES: To investigate the ability of six contemporary active surveillance protocols to appropriately select active surveillance candidates among Korean men who underwent radical prostatectomy.
METHODS: Between January 2001 and December 2011, 1968 patients underwent radical prostatectomy for prostate cancer at Samsung Medical Center, Seoul, Korea. Patients met the criteria for active surveillance according to six currently used criteria, including those from the Johns Hopkins Hospital, the University of Toronto, the University of California at San Francisco, the Prospective Prostate Cancer Research International Active Surveillance, the University of Miami and the Memorial Sloan-Kettering Cancer Center. The rates of Gleason score upgrading, upstaging and misclassification at final pathology were assessed.
RESULTS: Among 1006 assessable patients, the percentage of men eligible for active surveillance varied from 13.5% to 38.5%, depending on the criteria used. The rates of upgrading ranged from 41.6% to 50.6%. Extracapsular extension was reported in 4.1% to 8.5% of patients, whereas seminal vesicle invasion was reported in 0.5% to 1.6% of patients. The upstaging rates according to the six active surveillance criteria varied from 4.5% to 9.3%, and the rates of misclassification varied from 44.5% to 54.8%.
CONCLUSIONS: Currently available active surveillance criteria might not be suitable in Korean patients with prostate cancer, as they have a high likelihood of underestimating cancer.
© 2013 The Japanese Urological Association.

Entities:  

Keywords:  active surveillance; clinical protocols; insignificant; prostate cancer; radical prostatectomy

Mesh:

Year:  2013        PMID: 24168232     DOI: 10.1111/iju.12326

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  18 in total

1.  Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.

Authors:  Tae Heon Kim; Jae Yong Jeong; Sin Woo Lee; Chan Kyo Kim; Byung Kwan Park; Hyun Hwan Sung; Hwang Gyun Jeon; Byong Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi; Seong Soo Jeon
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

2.  Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?

Authors:  Pietro Pepe; Antonio Garufi; Giandomenico Priolo; Michele Pennisi
Journal:  World J Urol       Date:  2015-12-23       Impact factor: 4.226

Review 3.  Active surveillance for prostate cancer.

Authors:  Javier Romero-Otero; Borja García-Gómez; José M Duarte-Ojeda; Alfredo Rodríguez-Antolín; Antoni Vilaseca; Sigrid V Carlsson; Karim A Touijer
Journal:  Int J Urol       Date:  2015-11-30       Impact factor: 3.369

4.  An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients.

Authors:  Vitor da Silva; Ilias Cagiannos; Luke T Lavallée; Ranjeeta Mallick; Kelsey Witiuk; Sonya Cnossen; James A Eastham; Dean A Fergusson; Chris Morash; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2017-08       Impact factor: 1.862

5.  Diagnostic Accuracy of Contemporary Selection Criteria in Prostate Cancer Patients Eligible for Active Surveillance: A Bayesian Network Meta-Analysis.

Authors:  Yu Fan; Yelin Mulati; Lingyun Zhai; Yuke Chen; Yu Wang; Juefei Feng; Wei Yu; Qian Zhang
Journal:  Front Oncol       Date:  2022-01-10       Impact factor: 6.244

6.  Pathologic Outcomes in Men with Low-risk Prostate Cancer Who Are Potential Candidates for Contemporary, Active Surveillance Protocols.

Authors:  Ho Won Kang; Joo Yong Lee; Jong Kyou Kwon; Seong Uk Jeh; Hae Do Jung; Kang Su Cho; Won Sik Ham; Young Deuk Choi
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

7.  The role of 3-tesla diffusion-weighted magnetic resonance imaging in selecting prostate cancer patients for active surveillance.

Authors:  Chang Wook Jeong; Yong Hyun Park; Sung Ii Hwang; Sangchul Lee; Seong Jin Jeong; Sung Kyu Hong; Seok-Soo Byun; Hak Jong Lee; Sang Eun Lee
Journal:  Prostate Int       Date:  2014-12-30

Review 8.  Active surveillance for prostate cancer: a narrative review of clinical guidelines.

Authors:  Sophie M Bruinsma; Chris H Bangma; Peter R Carroll; Michael S Leapman; Antti Rannikko; Neophytos Petrides; Mahesha Weerakoon; Leonard P Bokhorst; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2016-01-27       Impact factor: 14.432

9.  The clinical impact of strict criteria for active surveillance of prostate cancer in Korean population: Results from a prospective cohort.

Authors:  Jungyo Suh; Hyeong Dong Yuk; Minyong Kang; Bum Sik Tae; Ja Hyeon Ku; Hyeon Hoe Kim; Cheol Kwak; Chang Wook Jeong
Journal:  Investig Clin Urol       Date:  2021-04-30

10.  Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.

Authors:  G L Shaw; B C Thomas; S N Dawson; G Srivastava; S L Vowler; V J Gnanapragasam; N C Shah; A Y Warren; D E Neal
Journal:  Br J Cancer       Date:  2014-04-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.